Circulating miR-21 levels in hypertensive patients with asymptomatic organ damage.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Sep 2019
Historique:
entrez: 3 10 2019
pubmed: 3 10 2019
medline: 11 10 2019
Statut: ppublish

Résumé

As a modifiable risk factor for cardiovascular disease, presence of hypertension (HT) necessitates the awareness of asymptomatic organ damage (AOD). The aim of this study was to measure plasma micro RNA-21 (miR-21) and the parameters that reflect AOD such as carotid intima-media thickness (CIMT), microalbuminuria (MAU) in hypertensive patients compared with healthy controls. In addition, the aim of this study was to evaluate plasma miR-21 levels in HT patients with AOD.This study was designed as a cross-sectional observational study. The study includes 2 groups: 32 patients with HT and 32 healthy controls. First, we compared these 2 groups. Then, to underline the relationship between plasma miR-21 and HT, hypertensive patients were divided into 2 groups: with AOD and without AOD.Sixteen patients with HT had AOD. MiR-21 levels significantly correlated with clinical systolic and diastolic blood pressure, MAU, C-reactive protein, and CIMT. CIMT, miR-21, and MAU levels were significantly higher in patients with AOD.Our study showed increased miR-21 levels in HT patients with AOD.

Identifiants

pubmed: 31574853
doi: 10.1097/MD.0000000000017297
pii: 00005792-201909270-00062
pmc: PMC6775376
doi:

Substances chimiques

Circulating MicroRNA 0
MIRN21 microRNA, human 0
MicroRNAs 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17297

Références

Nature. 2008 Dec 18;456(7224):980-4
pubmed: 19043405
Clin Exp Hypertens. 2015;37(8):643-9
pubmed: 26114349
Circ Res. 2007 Jun 8;100(11):1579-88
pubmed: 17478730
Hypertension. 2012 Feb;59(2):513-20
pubmed: 22215713
J Hypertens. 2013 Jun;31(6):1083-5
pubmed: 23636014
Medicine (Baltimore). 2015 Apr;94(13):e693
pubmed: 25837765
Blood Press. 2014 Feb;23(1):3-16
pubmed: 24359485
Am J Hypertens. 2011 Jan;24(1):52-8
pubmed: 20847724
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Hypertens. 2004 Jan;22(1):11-9
pubmed: 15106785
J Am Coll Cardiol. 2006 Sep 5;48(5):980-2
pubmed: 16949490
J Hum Hypertens. 2015 Feb;29(2):92-8
pubmed: 25007999
Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2512-21
pubmed: 18978195
J Clin Hypertens (Greenwich). 2013 Oct;15(10):742-7
pubmed: 24088283
J Am Heart Assoc. 2013 Apr 08;2(2):e000087
pubmed: 23568342

Auteurs

Erkan Yildirim (E)

Department of Cardiology.

Emrah Ermis (E)

Department of Cardiology.

Samir Allahverdiyev (S)

Department of Cardiology.

Hakan Ucar (H)

Department of Cardiology.

Serap Yavuzer (S)

Department of Internal Medicine, Biruni University Faculty of Medicine, İstanbul, Turkey.

Mahir Cengiz (M)

Department of Internal Medicine, Biruni University Faculty of Medicine, İstanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH